Dr. Saif is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Karmanos Cancer Institute
4100 John R St
Detroit, MI 48201- Is this information wrong?
Summary
- Recognized as an internationally renowned expert and Key Opinion Leader (KOL) in the fields of Gastrointestinal (GI) cancers, Experimental Therapeutics and Pharmacogenetics. I have distinguished myself in terms of clinical care, teaching, research and administration. I do carry the vision of a strategic leader with knowledge and experience in academic institutions, health centers, and teaching hospitals. I have demonstrated experience as a leader who inspires faculty and staff to work together to maximize the potential of the department. I understand cancer research and cancer care from the perspective of personal clinical practice experience. I have participated in the management of clinical enterprise and demonstrated an understanding of the issues involved.
I have cultured over the years, the qualities of leadership, collaboration, communication, and fairness, which all are required to perform any executive job. I am always considered as a valuable member and an effective leader of successful multi-disciplinary cancer management teams with a passion for mentoring and thrives in highly pressurized working environments.
I have published over 600 peer-reviewed articles about cancer treatment and research and over 90 abstracts, and over 2 dozens of book chapters.
I have been selected as the “America's Top Oncologist” as well as the “Leading physician of the World”.
In summary, I have been blessed to contribute to both society and science with a proven track record of significant achievements in the context of clinical research, teaching, mentoring and administration. I owe my successes to God, my parents, patients, family, friends and peers.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- University of ConnecticutResidency, Internal Medicine, 1995 - 1998
- Mayo HospitalInternship, 1993 - 1994
- King Edward Medical UniversityClass of 1993
- F.G. Sir Syed CollegePre-Medical/F.Sc./H.S.C., 1984 - 1986
Certifications & Licensure
- MI State Medical License 2023 - 2026
- IL State Medical License 2024 - 2026
- FL State Medical License 2022 - 2024
- NY State Medical License 2010 - 2024
- MA State Medical License 2012 - 2019
- CT State Medical License 2005 - 2011
- AL State Medical License Active through 2005
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Top Doctors off New York Usa News, 2019
- Compassionate Doctor Award - 5 Year Honoree 2018
- USA TOP Doctor Castle Conolley, 2018
- Join now to see all
Clinical Trials
- Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. Start of enrollment: 2006 May 01
- A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma Start of enrollment: 2006 Dec 01
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genesMuhammad Wasif Saif, Ruchi Hamal, Nauman S Siddiqui, Antonia Maloney, Melissa H Smith> ;Therapeutic Advances in Gastroenterology. 2021 Jul 3
- 24 citationsThe role of PARP inhibitors in BRCA mutated pancreatic cancerJeffrey Chi, Su Yun Chung, Ruwan Parakrama, Fatima Fayyaz, Jyothi Jose, Muhammad Wasif Saif> ;Therapeutic Advances in Gastroenterology. 2021 May 10
- 1 citationsDoes Neoadjuvant Therapy Improve Outcome in Resectable PC? Gastrointestinal Cancers Symposium 2019.Maged Ghaly, Muhammad Wasif Saif> ;JOP. 2019 Nov 1
- Join now to see all
Journal Articles
- Pancreatic cancer: new hopes for early detection and a future screening tool?El-Jurdi NH, Saif MW, Journal of Pancreas, 1/28/2014
- Role of neoadjuvant therapy in management of pancreatic cancerLi J, Saif MW, Journal of Pancreas, 1/28/2014
- Targeted agents in treatment of neuroendocrine tumors of pancreasKarampelas IN, Syrigos KN, Saif MW, Journal of Pancreas, 1/28/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Clinical Outcomes in Pancreatic Adenocarcinoma Associated with BRCA2 Mutation.Vyas O, Keith L, Saif MW, Pancreas Club, 1/1/2014
- A phase I study of metformin and chemotherapy in solid tumors.Athena Kritharis, Jennifer Caplain, Shrikar Rajagopal, Elizabeth Grimm, Philip N. Tsichlis, Robert Martell, Saif MW, J Clin Oncol, 1/1/2014
- A pilot study evaluating the safety and impact of pretreatment with metformin on colorectal cancer stem cells (CCSC) in patients undergoing resection.Nicholas C. DeVito, Martin D. Goodman, Jennifer Caplain, Shrikar Rajagopal, Daniel Popowich, Bruce A Orkin, Elizabeth Grimm, Philip N. Tsichlis, Robert E. Martell, Sai..., J Clin Oncol, 1/1/2014
- Join now to see all
Lectures
- "Use of metformin in Clinical trials"New Orleans, LA - 1/1/2014
- "Grand Rounds"Multiple locations, 2012-2010 - 1/1/2013
- "Hem-Onc Grand Rounds"Multiple locations, 2012-2010 - 1/1/2013
- Join now to see all
Other
- Editor: "Pancreatic Neoplasm, Jaypee Brothers Medical Publishers Private Limited, New Delhi, India"Goodman M, Saif MW
1/1/2013 - Cancer Vaccines.Saif MW, Hemonc Today
1/25/2011 - Erlotinib Only Biologic to Improve Survival in Pancreatic Cancer: Commentary in Medscape.Saif MW
http://www.medscape.com/viewarticle/555897?rss
1/1/2007 - Join now to see all
Press Mentions
- Orlando Health Launches Seamless Pancreatic Cancer CareNovember 2nd, 2022
- Orlando Health Cancer Institute Welcomes New Gastrointestinal Cancer ExpertJune 22nd, 2022
- High Cholesterol Levels May Impact Your Risk of Certain Cancers: What We KnowAugust 30th, 2021
- Join now to see all
Grant Support
- NCORPNorthwellHealth2019–Present
- NCI-SPOREUAB2003–Present
- TP Upregulation and Capecitabine CombosUAB2002–Present
- DPD Deficiency SyndromeUAB2001–Present
- UL1 TR001064NCIPresent
Committees
- PI, SWOG 2020 - Present
- Chair, GI Commitee, Chemotherapy Foundation 2019 - Present
- Founding Steering Member Faculty, Lustgarten Foundation for Pancreatic cancer 2019 - Present
- see above, Editorial Position including Chief Editor, Senior, Associate, Section 2012 - 2018
- Member, ASCO
- Member, Pancreas Club
- Member, ACOSOG
- Member, ECOG
- Member, NCCN
Research History
- co-PINCORP NorthwellHealth2020 - Present
- Principal InvestigatorSWOG NorthwellHealth2020 - Present
- Principal InvestigatorPerformed over 70 Phase I,II and III studies in solid tumors especially GI Cancers1999 - 2014
Professional Memberships
- Member
- Member
- New York StateMember
- NY GenomeMember
Other Languages
- Hindi, Urdu, Punjabi
Industry Relationships
- Advisor and Speaker, Ipsen, Novartis, Lexicon, Genentech, Celgene
External Links
- Linkedinhttps://www.linkedin.com/profile/guided-edit-entry-point
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: